Article
The combination of ANT2 shRNA and hNIS radioiodine gene therapy increases CTL cytotoxic activity through the phenotypic modulation of cancer cells: combination treatment with ANT2 shRNA and I-131.
BMC cancer - 22 Mar 2013
Choi Yun, Lee Ho Won, Lee Jaetae, Jeon Yong Hyun
Abstract excerpt
BACKGROUND: It is important to simultaneously induce strong cell death and antitumor immunity in cancer patients for successful cancer treatment. Here, we investigated the cytotoxic and phenotypic modulation effects of the combination of ANT2 shRNA and human sodium iodide symporter (hNIS) radioiodine gene therapy in vitro and in vivo and visualized the antitumor effects in an immunocompromised mouse colon cancer...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.